arginine vasopressin has been researched along with opc 51803 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyama, M; Hirano, T; Itoh, S; Kambe, T; Kan, K; Kondo, K; Mori, T; Nakamura, S; Nakayama, S; Ogawa, H; Sekiguchi, K; Shinohara, T; Sumida, T; Tanada, Y; Teramoto, S; Tominaga, M; Tsujimae, K; Tsujimoto, G; Yamamura, Y | 1 |
| Aoyama, M; Hirano, T; Kondo, K; Mori, T; Nakamura, S; Tominaga, M; Tsujimae, K; Yamamura, Y | 1 |
2 other study(ies) available for arginine vasopressin and opc 51803
| Article | Year |
|---|---|
Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes.
Topics: Arginine Vasopressin; Benzazepines; Binding, Competitive; Calcium; Cyclic AMP; Deamino Arginine Vasopressin; HeLa Cells; Hemostatics; Humans; Pyrrolidines; Receptors, Vasopressin; Transfection; Vasopressins | 2000 |
Antidiuretic effects of a nonpeptide vasopressin V(2)-receptor agonist, OPC-51803, administered orally to rats.
Topics: Administration, Oral; Animals; Arginine Vasopressin; Benzazepines; Blood Pressure; Creatinine; Diabetes Insipidus; Diuresis; Dose-Response Relationship, Drug; Female; Kidney; Liver; Male; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin | 2000 |